{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:47:16Z","timestamp":1793400436515,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13630-8","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:21:01Z","timestamp":1762960861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Barriers and enablers of elderly care specialists towards deprescribing practices in the nursing homes: a focus group study"],"prefix":"10.1186","volume":"25","author":[{"given":"Alireza","family":"Malek Makan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"van Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"van Marum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"13630_CR1","doi-asserted-by":"crossref","unstructured":"Oktora MP, et al. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States. PLoS One. 2019;14(3):e0214240.","DOI":"10.1371\/journal.pone.0214240"},{"key":"13630_CR2","doi-asserted-by":"crossref","unstructured":"Wastesson J, Morin L, Tan E, Johnell K. An update on the clinical consequences of polypharmacy in older adults a narrative review. Exp Opin Drug Saf. 2018:17(12):1185\u20131196.","DOI":"10.1080\/14740338.2018.1546841"},{"issue":"12","key":"13630_CR3","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/11319530-000000000-00000","volume":"26","author":"J Jyrkk\u00e4","year":"2009","unstructured":"Jyrkk\u00e4 J, Enlund H. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039\u201348.","journal-title":"Drugs Aging"},{"key":"13630_CR4","doi-asserted-by":"crossref","unstructured":"Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medication to combat polyfarmacy. Ther Adv Drug Saf. 2015;6(6):212\u201333.","DOI":"10.1177\/2042098615613984"},{"issue":"1","key":"13630_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660.","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"13630_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging defnition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Brit J Clin Pharmaco. 2015;80(6):1254\u201368. https:\/\/doi.org\/10.1111\/bcp.12732.","journal-title":"Brit J Clin Pharmaco"},{"key":"13630_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2016.12.021.","journal-title":"Eur J Intern Med"},{"key":"13630_CR8","doi-asserted-by":"publisher","first-page":"008165","DOI":"10.1002\/14651858.CD008165.pub3","volume":"10","author":"SM Patterson","year":"2014","unstructured":"Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Db Syst Rev. 2014;10:008165. https:\/\/doi.org\/10.1002\/14651858.CD008165.pub3.","journal-title":"Cochrane Db Syst Rev"},{"key":"13630_CR9","doi-asserted-by":"publisher","first-page":"009095","DOI":"10.1002\/14651858.CD009095.pub3","volume":"2","author":"DP Alldred","year":"2016","unstructured":"Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P. Interventions to optimise prescribing for older people in care homes. Cochrane Db Syst Rev. 2016;2:009095. https:\/\/doi.org\/10.1002\/14651858.CD009095.pub3.","journal-title":"Cochrane Db Syst Rev"},{"issue":"2","key":"13630_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jgs.15195","volume":"66","author":"SL Gray","year":"2018","unstructured":"Gray SL, Hart LA, Perera S, Semla TP, Schmader KE, Hanlon JT. Meta-analysis of interventions to reduce adverse drug reactions in older adults. J Am Geriatr Soc. 2018;66(2):282\u20138. https:\/\/doi.org\/10.1111\/jgs.15195.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"13630_CR11","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/jgs.17273","volume":"69","author":"KM Zimmerman","year":"2021","unstructured":"Zimmerman KM, Linsky AM. A narrative review of updates in deprescribing research. J Am Geriatr Soc. 2021;69(9):2619\u201324. https:\/\/doi.org\/10.1111\/jgs.17273.","journal-title":"J Am Geriatr Soc"},{"key":"13630_CR12","doi-asserted-by":"publisher","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","volume":"4","author":"K Anderson","year":"2014","unstructured":"Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.","journal-title":"BMJ Open"},{"key":"13630_CR13","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1177\/1049732316687732","volume":"27","author":"K Anderson","year":"2017","unstructured":"Anderson K, Foster M, Freeman C, et al. Negotiating unmeasurable harm and beneft: perspectives of general practitioners and consultant pharmacists on deprescribing in the primary care setting. Qual Health Res. 2017;27:1936\u201347.","journal-title":"Qual Health Res"},{"key":"13630_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1071\/PY18056","volume":"24","author":"R Gillespie","year":"2018","unstructured":"Gillespie R, Mullan J, Harrison L. Deprescribing for older adults in australia: factors infuencing gps. Aust J Prim Health. 2018;24:463\u20139.","journal-title":"Aust J Prim Health"},{"issue":"3","key":"13630_CR15","doi-asserted-by":"publisher","first-page":"bjgpopen20X1010","DOI":"10.3399\/bjgpopen20X101096","volume":"4","author":"AJ Doherty","year":"2020","unstructured":"Doherty AJ, Boland P, Reed J, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020;4(3):bjgpopen20X101096.","journal-title":"BJGP Open"},{"key":"13630_CR16","doi-asserted-by":"publisher","unstructured":"Lau S, Lun P, Ang W, et al. Barriers to effective prescribing in older adults: applying the theoretical. 2020;20(1):459. https:\/\/doi.org\/10.1186\/s12877-020-01766-7","DOI":"10.1186\/s12877-020-01766-7"},{"issue":"2","key":"13630_CR17","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1111\/ajag.12220","volume":"35","author":"CP Heppenstall","year":"2016","unstructured":"Heppenstall CP, Broad JB, Boyd M, et al. Medication use and potentially inappropriate medications in those with limited prognosis living in residential aged care. Australas J Ageing. 2016;35(2):E18\u201324.","journal-title":"Australas J Ageing"},{"issue":"1","key":"13630_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1179\/174329111X576698","volume":"19","author":"AR Maddison","year":"2011","unstructured":"Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15\u201321.","journal-title":"Prog Palliat Care"},{"issue":"7","key":"13630_CR19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/jgs.14844","volume":"65","author":"JN Matlow","year":"2017","unstructured":"Matlow JN, Bronskill SE, Gruneir A, et al. Use of medications of questionable benefit at the end of life in nursing home residents with advanced dementia. J Am Geriatr Soc. 2017;65(7):1535\u201342.","journal-title":"J Am Geriatr Soc"},{"key":"13630_CR20","doi-asserted-by":"crossref","unstructured":"Morin L, Vetrano DL, Grande G, Fratiglioni L, Fastbom J, Johnell K. Use of medications of questionable benefit during the last year of life of older adults with dementia. J Am Med Dir Assoc. 2017;18(6):e5511\u20137.","DOI":"10.1016\/j.jamda.2017.02.021"},{"key":"13630_CR21","doi-asserted-by":"crossref","unstructured":"Morin L, Vetrano DL, Rizzuto D, Calder\u00f3n-Larra\u00f1aga A, Fastbom J, Johnell K. Choosing wisely? Measuring the burden of medications in older adults near the end of life: Nationwide, longitudinal cohort study. Am J Med. 2017;130(8):927\u201336. e9.","DOI":"10.1016\/j.amjmed.2017.02.028"},{"key":"13630_CR22","doi-asserted-by":"crossref","unstructured":"McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51(2):178\u201383.e2.","DOI":"10.1016\/j.jpainsymman.2015.09.003"},{"key":"13630_CR23","doi-asserted-by":"crossref","unstructured":"Poudel A, Yates P, Rowett D, Nissen LM. Use of preventive medication in patients with limited life expectancy: a systematic review. J Pain Symptom Manage. 2017;53(6):1097\u20131110.e1.","DOI":"10.1016\/j.jpainsymman.2016.12.350"},{"key":"13630_CR24","doi-asserted-by":"publisher","unstructured":"Malek Makan A, et al. Potentially inappropriate medications according to STOPP-Frail criteria in European Nursing Home residents with cognitive impairment and end-stage disease. 2024;24(1):882. https:\/\/doi.org\/10.1186\/s12877-024-05450-y","DOI":"10.1186\/s12877-024-05450-y"},{"key":"13630_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s41999-022-00702-9","volume":"13","author":"EP Poelgeest van","year":"2022","unstructured":"Poelgeest van EP, et al. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across europe: a large web-based survey. Eur Geriatr Med. 2022;13:1455\u201366.","journal-title":"Eur Geriatr Med"},{"key":"13630_CR26","doi-asserted-by":"publisher","unstructured":"Abou J, et al. Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: a focus group study. Drugs Aging. Published: 2022;39:209\u2013221. https:\/\/doi.org\/10.1007\/s40266-021-00918-7","DOI":"10.1007\/s40266-021-00918-7"},{"key":"13630_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12877-020-01766-7","volume":"20","author":"S Lau","year":"2020","unstructured":"Lau S, Lun P, Ang W, et al. Barriers to efective prescribing in older adults: applying the theoretical domains framework in the ambulatory setting\u2014a scoping review. BMC Geriatr. 2020;20:459.","journal-title":"BMC Geriatr"},{"issue":"5","key":"13630_CR28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/bcp.13861","volume":"85","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graabaek T, Ryg J, S\u00f8ndergaard J, Potteg\u00e5rd A, Nielsen DS. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: A systematic review. Br J Clin Pharmacol. 2019;85(5):868\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"13630_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2296-13-56","volume":"13","author":"J Schuling","year":"2012","unstructured":"Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56. Published 2012 Jul 9.","journal-title":"BMC Fam Pract"},{"key":"13630_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12877-016-0181-x","volume":"16","author":"A Palagyi","year":"2016","unstructured":"Palagyi A, Keay L, Harper J, Potter J, Lindley RI. Barricades and brickwalls - a qualitative study exploring perceptions of medication use and deprescribing in long-term care. BMC Geriatr. 2016;16:15. Published 2016 Jan 15.","journal-title":"BMC Geriatr"},{"key":"13630_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40266-023-01092-8","volume":"41","author":"AG Visser","year":"2024","unstructured":"Visser AG, R\u00b7 Poddighe de\u2013Bruijn JB, G\u00b7. Spaetgens B\u00b7 Winkens B\u00b7 Janknegt R\u00b7 schols J M G A. Unlocking deprescribing potential in nursing homes: insights from a focus group study with healthcare professionals. Drugs Aging. 2024;41:261\u201370.","journal-title":"Drugs Aging"},{"key":"13630_CR32","unstructured":"Factsheet Verblijfsduur verpleeghuispati\u00ebnten langer dan negen maanden. Verenso; 2019 Jan 30. https:\/\/www.verenso.nl\/_asset\/_public\/Nieuws\/20190130-Verenso_Factsheet-verblijfsduur.pdf"},{"key":"13630_CR33","doi-asserted-by":"crossref","unstructured":"Wouters H, Foster JM, Ensink A, Kouladjian O\u2019Donnell L, Zuidema SU, Boersma F, Taxis K. Barriers and facilitators of conducting medication reviews in nursing home residents: a qualitative study. Front Pharmacol. 2019;10:1026.","DOI":"10.3389\/fphar.2019.01026"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13630-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:21:05Z","timestamp":1762960865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13630-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13630"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13630-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The participants agreed with the audio recording in order to analysis and publication, the name of the participant and the work location were not included. Informed consent to participate was obtained from all of the participants in the study. Also no patient data were included. The study protocol was conducted in compliance with Dutch regulations governing qualitative research with healthcare professionals. These regulations state that review by a certified medical ethics committee was not required, as the study did not involve patients or invasive interventions and therefore did not require ethical approval. Dutch legislation regarding this matter is outlined on the official website: Your research: Is it subject to the WMO or not? | Investigators | The Central Committee on Research Involving Human Subjects Our study also adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1466"}}